Results

Total Results: 3,024 records

Showing results for "diseases".

281. Computerized Definitions Showed High Positive Predictive Values for Identifying Reasons for Hospitalizations in a Medicaid Population with Rheumatoid Arthritis (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/rheumatoid-arthritis-hospitalizations_research.pdf
     October 01, 2008 - selected common (pneumonia and congestive heart failure) and less frequent (sepsis, invasive pneumococcal diseases … serious renal (patients on hemodialysis), liver (hepatic coma and hepatorenal syndrome), or respiratory diseases … definitions for community-acquired pneumonia, sepsis, congestive heart failure, invasive pneumococcal diseases … Assessing the ability of our definitions to identify rare conditions, such as invasive pneumococcal diseases … This PPV depends on disease prevalence and the specificity of the definitions7, and when disease prevalence

282. Screening for and Management of Chronic Kidney Disease Stages 1-3 | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/kidney-disease-medicine/research-protocol
     July 28, 2010 - First, CKD shares many of the same risk factors as other vascular diseases, such as older age, hypertension … Causes of CKD can be broken down into primary kidney diseases (predominantly glomerular diseases, tubulointerstitial … diseases, obstruction, and polycystic kidney disease) versus those in which the kidney damage is secondary … (e.g., coronary artery disease [CAD], peripheral arterial disease [PAD], cerebrovascular disease [CVD … and kidney disease.

283. Discontinuation of Disease-Modifying Treatment for Multiple Sclerosis | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/multiple-sclerosis/research-protocol
     December 17, 2013 - However, generally people will reach a stage in their personal disease course where disease modifying … of the disease in the long-run and when to discontinue disease-modifying treatment. … What are patient and provider preferences for discontinuation of disease–modifying therapies? … When should a patient discontinue disease-modifying treatment? … FDA-approved disease modifying drugs were only available after 1993.

284. Disposition of Comments for CER 162 Diagnosis of Celiac Disease (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/celiac-disease_disposition-comments.pdf
     January 28, 2016 - Diagnosis of Celiac Disease. Comparative Effectiveness Review No. 162. … 3) What are the long-term implications of undiagnosed celiac disease? … celiac disease, at-risk groups and asymptomatic celiac disease? … Commentator & Affiliation Section Comment Response celiac disease? … What exactly is meant by “active celiac disease”?

285. Effective Health Care (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0334_08-04-2010.pdf
     January 01, 2010 - events (e.g., ischemic stroke, symptomatic peripheral arterial disease), or (3) undergoing percutaneous … s): (1) Patients with acute coronary syndrome, (2) patients who have suffered other cardiovascular disease-related … events (e.g., ischemic stroke, symptomatic peripheral arterial disease), or (3) patients undergoing … Outcome(s): Recurrent ischemic events, stent thromboses, cardiovascular disease- related morbidity and …  While clopidogrel may decrease morbidity and mortality associated with several cardiovascular diseases

286. Comparative Effectiveness of Treatment Strategies for Women With Coronary Artery Disease | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/cad-women-treatment/research-protocol
     January 24, 2011 - Coronary disease risk factors such as diabetes, chronic kidney disease, or other comorbid disease? … Coronary disease risk factors such as diabetes, chronic kidney disease, or other comorbid disease? … Coronary disease risk factors such as diabetes, chronic kidney disease, or other comorbid disease? … risk factors such as diabetes, chronic kidney disease, or other comorbid disease Angiographic-specific … Proposed Search Strategy cardiovascular diseases OR heart diseases OR heart OR cardiovas* OR cardiac

287. Outreach to Patient and Consumer Representatives (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/branson-text.pdf
     October 13, 2011 - providers Slide 4 Characteristics of Patient Representatives § Have personal experience with the disease … § Are knowledgeable about treatment options and/or the science of the disease § Are able to be objective … groups may offer an opportunity to identify patients who might be underrepresented (such as for rare diseases … Advocacy experience § Ability to represent other patients/survivors § Knowledge and skills related to disease … area § Alternate disease experience § Work experience § Education § Interview representatives.

288. Pharmacologic Therapies for the Management of Crohn's Disease: Comparative Effectiveness | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/crohns-disease
     September 01, 2010 - Pharmacologic Therapies for the Management of Crohn's Disease: Comparative Effectiveness … Archived Comparative Effectiveness of Pharmacologic Therapies for the Management of Crohn’s Disease … Systematic Review Archived Pharmacologic Therapies for the Management of Crohn’s Disease

289. Effective Health Care (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0068_01-30-2009.pdf
     January 01, 2009 - laboratory tests can have great utility in the diagnosis and management of patients with rheumatic diseases

290. Medication-Therapy-Management Research-Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/medication-therapy-management_research-protocol.pdf
     January 01, 2014 - CMS required that MTM programs target Medicare Part D enrollees, who have multiple chronic diseases, … obstructive pulmonary disease), bone disease (e.g., osteoporosis, osteoarthritis, rheumatoid arthritis … ), and mental health diseases. … Patient-centered outcomes, such as disease-specific morbidity, disease-specific or all- cause mortality … symptoms, reduced number of disease- specific acute exacerbations or events)  Disease-specific or

291. Mortality Risk in Chronic Obstructive Pulmonary Disease Patients Using Theophylline | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/copd-management/research
     December 04, 2009 - Mortality Risk in Chronic Obstructive Pulmonary Disease Patients Using Theophylline Research Report … Participants Patients with a diagnosis of chronic obstructive pulmonary disease that were 45 years … adn Main Results Primary outcome measures were all-cause mortality, chronic obstructive pulmonary disease … exacerbations and chronic obstructive pulmonary disease-related hospitalizations. … that included theophylline had slightly increased risks of mortality, chronic obstructive pulmonary disease

292. Comparative Effectiveness of Percutaneous Coronary Interventions and Coronary Artery Bypass Grafting for Coronary Artery Disease | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/cad-pci-bypass/research
     October 15, 2007 - Effectiveness of Percutaneous Coronary Interventions and Coronary Artery Bypass Grafting for Coronary Artery Disease … CABG is generally preferred for patients with left main coronary artery disease or severe triple-vessel … disease with reduced left ventricular function because it has been previously shown in randomized trials … The choice between PCI and CABG is most relevant for patients whose coronary artery disease (CAD) lies … in between these extremes, namely patients with single-vessel disease of the proximal left anterior

293. Comparative Effectiveness of Coronary Bypass Surgery and Percutaneous Coronary Interventions for Multivessel Disease: A Pooled Analysis of Individual Patient Data from Ten Randomized Trials (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cad-pci-bypass_addendum.pdf
     February 01, 2010 - Comparative Effectiveness of Coronary Bypass Surgery and Percutaneous Coronary Interventions for Multivessel Disease … Consequently, patients with extensive three-vessel disease or left main disease were generally excluded … Continuing evolution of therapy for coronary artery disease. … Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. … PVD = peripheral vascular disease.

294. Noninvasive Testing for Coronary Artery Disease | Effective Health Care Program
     effectivehealthcare.ahrq.gov/products/coronary-artery-disease-testing
     January 15, 2015 - Noninvasive Testing for Coronary Artery Disease Timeline January 29, 2014 Topic Initiated … 15, 2015 Research Protocol Archived Noninvasive Testing for Coronary Artery Disease … 29, 2016 Systematic Review Archived Noninvasive Testing for Coronary Artery Disease

295. Interventions for Preventing Cognitive Decline, Mild Cognitive Impairment, and Alzheimer’s Disease | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/cognitive-decline/research-protocol
     March 23, 2016 - Additionally, dementia-related expenses exceed those for other diseases, including heart disease and … kidney disease, and loss of hearing and/or vision. … We will examine the treatment of diseases such as cardiovascular disease, cerebrovascular disease, hypertension … Preventing Alzheimer's disease and cognitive decline. … Advances in the prevention of Alzheimer's disease and dementia.

296. Crosscutting-Horizon-Scan-High-Impact-1412 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/crosscutting-horizon-scan-high-impact-1412.pdf
     December 01, 2014 - of American Anesthesiologist (ASA) physical performance status IV (patients with severe systemic disease … number (n=17) of the overall patient population had an ASA performance status of III (severe systemic disease …  Education: residency and continuing medical education should include unique physiology, atypical disease … HS262 - Intelligent pills (Raisin System) to monitor patient medication use in chronic diseases. … HS262 - Intelligent pills (Raisin System) to monitor patient medication use in chronic diseases.

297. Topic Brief: Screening and Treating Non-Alcoholic Fatty Liver Disease (pdf file)
     effectivehealthcare.ahrq.gov/system/files/docs/na_liver_disease_topic_brief_topic_brief.pdf
     October 30, 2020 - Topic Brief: Screening and Treating Non-Alcoholic Fatty Liver Disease 1 Topic Brief: Screening … and Treating Non-Alcoholic Fatty Liver Disease Date: 10/30/2020 Nomination Number: 0939 Purpose … Guidelines from the American Association for the Study of Liver Diseases do not recommend screening … Screening for Nonalcoholic Fatty Liver Disease in the Primary Care Clinic. … Association for the Study of Liver Diseases.

298. Evidence-Summary-CER-206-Sodium-And-Potassium-Intake-Effects-On-Chronic-Disease-Outcomes-And-Risk (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-206-evidence-summary-sodium-potassium.pdf
     June 01, 2018 - A primary risk factor for CVD (cardiovascular disease), stroke, and other circulatory diseases is … dietary sodium reduction and increased potassium intake on blood pressure and risk for cardiovascular diseases … diseases, requires that the findings from observational studies be subjected to greater scrutiny and … potassium intake, blood pressure, incident hypertension, and risk for all-cause mortality, chronic diseases … The age-specific quantitative effects of metabolic risk factors on cardiovascular diseases and diabetes

299. DEcIDE 33: Summary Variables in Observational Resesarch: Propensity Scores and Disease Risk Scores (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/observational-research-scores_research.pdf
     May 01, 2012 - groups for hospital discharges, 10 diagnostic groups for outpatient visits, and 10 indicators of other diseases … However, the disease risk score estimates the probability or rate of disease (or outcome) occurrence … The association between exposure and disease (or outcome) is then estimated adjusting for the disease … Disease Risk Score Calculation Given that the disease risk score estimates the probability of disease … Disease Risk Score Assessment The disease risk score is often categorized into groups such that the

300. Summary Variables in Observational Research: Propensity Scores and Disease Risk Scores | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/observational-research-scores/research
     May 15, 2012 - groups for hospital discharges, 10 diagnostic groups for outpatient visits, and 10 indicators of other diseases … However, the disease risk score estimates the probability or rate of disease (or outcome) occurrence … The association between exposure and disease (or outcome) is then estimated adjusting for the disease … Disease Risk Score Calculation Given that the disease risk score estimates the probability of disease … Disease Risk Score Assessment The disease risk score is often categorized into groups such that the